Evidence map›Paper›PMID 23744963›Full record

ArticleILAR journal2012

Recruitment and biological consequences of histone modification of H3K27me3 and H3K9me3.

Joomyeong Kim, Hana Kim

Open access · bronzeAbstract read
In one paragraph

Article in ILAR journal, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 53 papers.

0numbers the graph read from it
0cells of the map it votes in
53citing papers in PubMed
2.1field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

53 citing papers in PubMed, 84 citations in OpenAlex.

  1. Trial
  2. The Crucial Role of Epigenetic Modifications in Wharton's Jelly Stem Cells.International journal of molecular sciences · 2025
    Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Joomyeong KimDepartment of Biological Sciences, Louisiana State University, Baton Rouge, LA 70803, USA. jkim@lsu.edu
Hana Kim
Louisiana State University · US

Funding

Imprinting studies of a paternally expressed Usp29 geneR01GM066225 · NIGMS · UNIVERSITY OF CALIF-LAWRNC LVRMR NAT LAB · PI KIM, JOOMYEONG · 2004 to 2013
$2.6M
Retrotransposon as a major source to epigenetic variations in the human genomeR15ES019118 · NIEHS · LOUISIANA STATE UNIV A&M COL BATON ROUGE · PI KIM, JOOMYEONG · 2010 to 2010
$436k
NIEHS NIH HHS R15 ES019118NIEHS NIH HHS R15-ES019118NIGMS NIH HHS R01 GM066225NIGMS NIH HHS R01-GM066225
6 · The paper itself

Abstract

Two histone marks, H3K27me3 and H3K9me3, are well known for their repressive roles in the genic and nongenic regions of metazoan genomes. Several protein complexes are known to be responsible for generating these marks, including polycomb repression complex 2 and several H3K9 methylases. Recent studies have shown that the targeting of these histone-modifying complexes within mammalian genomes may be mediated through several DNA-binding proteins, including AEBP2, JARID2, and YY1. In this review, we discuss the potential targeting mechanisms in light of the recent results that have been derived from genome-wide chromatin immunoprecipitation sequencing data and the in vivo functions of these two histone marks in light of the results derived from mouse and human genetic studies.

Indexed as

AnimalsChromatin ImmunoprecipitationHistonesHumansMiceModels, BiologicalPolycomb Repressive Complex 2Repressor ProteinsYY1 Transcription FactorAEBP2 protein, humanHistonesJARID2 protein, humanPolycomb Repressive Complex 2Repressor ProteinsYY1 protein, humanYY1 Transcription FactorAEBP2H3K27me3H3K9me3JARID2PRC2YY1

Identifiers

PMID23744963
PMCPMC3747788
OpenAlexW2125081662

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.